Special Notice / Hearing: None__
Vote Required: Majority
To: Honorable Board of Supervisors
From: Louise F. Rogers, Chief, San Mateo County Health
Marc Meulman, Director, Public Health, Policy and Planning
Subject: Amendment to the Agreement and Vendor Agreement with Hologic Sales and Services, LLC
RECOMMENDATION:
title
Adopt a resolution authorizing the Purchasing Agent to amend an agreement with Hologic Sales and Service, LLC, extending the term by 36 months through December 12, 2026, and increasing the amount by $1,452,240 to an amount not to exceed $3,109,161.
body
BACKGROUND:
On December 04, 2018, this Board adopted a resolution authorizing the Purchasing Agent to enter a Reagent Purchase and System Loan agreement with Hologic Sales and Service, LLC (Hologic). Under this agreement, Hologic would provide test kits and reagents for the collection of bodily fluids and the determination of symptoms indicating certain communicable diseases for the term of December 4, 2018, through December 3, 2023, in an amount not to exceed $1,890,000.
This Board waived the competitive bidding process that resulted in a vendor agreement with a sole source vendor.
DISCUSSION:
The Public Health Laboratory (PHL) is committed to optimizing its methodology for testing infectious diseases. Hologic offers products that use nucleic acid molecular testing procedures for chlamydia and gonorrhea tests through cervical swabs, urethral swabs, urine specimens, and other anatomical sites recommended by the Centers for Disease Control and Prevention. The automated platform used for chlamydia and gonorrhea testing also allows the PHL to test for HIV and hepatitis C viral load monitoring for San Mateo County Health clients.
Hologic, the only company in the market that provides FDA-approved molecular identification of mycobacteria, also has products and equipment that identify mycobacteria, such as tuberculosis.
For the reasons described above, Public Policy and Planning request that this Board authorize the amendment of Hologic’s existing agreement. Under this amendment, Hologic will provide adjustments to commitment levels and pricing on items listed. Hologic will also make upgrades to the Panther Fusion instrument, fluorometer, and module and continue to loan the molecular testing equipment to the County.
The rapid identification of diseases is a critical component in minimizing their impact on the safety of the public. It is anticipated that the number of tests for chlamydia/gonorrhea, mycobacteria, and HIV/Hepatitis C Viral Load will be 16,500, 180, and 1,250 tests, respectively.
PERFORMANCE MEASURE:
|
Measure |
FY 2022-23 Estimated |
FY 2023-24 Projected |
|
Number of tests for chlamydia and Gonorrhea |
16,303 tests |
16,500 tests |
|
Number of tests for Mycobacteria Identification |
156 tests |
180 tests |
|
Number of tests for HIV / Hepatitis C Viral Load |
1,149 tests |
1,250 tests |
FISCAL IMPACT:
The term of the amended agreement is December 4, 2018, through December 12, 2026. The amendment increases the agreement amount by $1,452,240 to an amount not to exceed $3,109,161 for the eight-year term. Of that amount, $523,353 is included in the Public Health Policy and Planning FY 2022-23 Adopted Budget. Similar arrangements will be made for future budget years.
The PHL has applied a cost-based testing fee schedule which covers the cost of reagents and supplies purchased under this vendor agreement.